BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32009944)

  • 1. Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson's Disease.
    Chambers NE; Lanza K; Bishop C
    Front Pharmacol; 2019; 10():1494. PubMed ID: 32009944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the therapeutic mechanism of pedunculopontine nucleus stimulation in Parkinson's disease?
    Thevathasan W; Moro E
    Neurobiol Dis; 2019 Aug; 128():67-74. PubMed ID: 29933055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats.
    Sharma PK; Wells L; Rizzo G; Elson JL; Passchier J; Rabiner EA; Gunn RN; Dexter DT; Pienaar IS
    Neurotherapeutics; 2020 Jul; 17(3):1120-1141. PubMed ID: 31965550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gait improvement by high-frequency stimulation of the subthalamic nucleus in Parkinsonian mice is not associated with changes of the cholinergic system in the pedunculopontine nucleus.
    Witzig VS; Alosaimi F; Temel Y; Schulz JB; Jahanshahi A; Tan SKH
    Neurosci Lett; 2023 Apr; 802():137134. PubMed ID: 36801348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pedunculopontine nucleus cholinergic lesion on gait and dyskinesia in hemiparkinsonian rats.
    Chambers NE; Coyle M; Sergio J; Lanza K; Saito C; Topping B; Clark SD; Bishop C
    Eur J Neurosci; 2021 Apr; 53(8):2835-2847. PubMed ID: 33426708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats.
    Pienaar IS; van de Berg W
    Exp Neurol; 2013 Oct; 248():213-23. PubMed ID: 23769975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pedunculopontine Nucleus Stimulation: Where are We Now and What Needs to be Done to Move the Field Forward?
    Morita H; Hass CJ; Moro E; Sudhyadhom A; Kumar R; Okun MS
    Front Neurol; 2014; 5():243. PubMed ID: 25538673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of pedunculopontine nucleus in sleep-wake cycle and cognition in humans: A systematic review of DBS studies.
    Ricciardi L; Sarchioto M; Morgante F
    Neurobiol Dis; 2019 Aug; 128():53-58. PubMed ID: 30710676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pedunculopontine nucleus deep brain stimulation in Parkinson's disease.
    Tykocki T; Mandat T; Nauman P
    Arch Med Sci; 2011 Aug; 7(4):555-64. PubMed ID: 22291786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep disorders in Parkinsonian macaques: effects of L-dopa treatment and pedunculopontine nucleus lesion.
    Belaid H; Adrien J; Laffrat E; Tandé D; Karachi C; Grabli D; Arnulf I; Clark SD; Drouot X; Hirsch EC; François C
    J Neurosci; 2014 Jul; 34(27):9124-33. PubMed ID: 24990932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal interaction between monoaminergic systems and the pedunculopontine nucleus: Implication in the mechanism of L-DOPA.
    Di Giovanni G; Chagraoui A; Puginier E; Galati S; De Deurwaerdère P
    Neurobiol Dis; 2019 Aug; 128():9-18. PubMed ID: 30149181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anterior and posterior pedunculopontine tegmental nucleus are involved in behavior and neuronal activity of the cuneiform and entopeduncular nuclei.
    Jin X; Schwabe K; Krauss JK; Alam M
    Neuroscience; 2016 May; 322():39-53. PubMed ID: 26880033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. rCBF changes associated with PPN stimulation in a patient with Parkinson's disease: a PET study.
    Strafella AP; Lozano AM; Ballanger B; Poon YY; Lang AE; Moro E
    Mov Disord; 2008 May; 23(7):1051-1054. PubMed ID: 18412282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep brain stimulation of the subthalamic and pedunculopontine nucleus in a patient with Parkinson's disease.
    Liu HG; Zhang K; Yang AC; Zhang JG
    J Korean Neurosurg Soc; 2015 Apr; 57(4):303-6. PubMed ID: 25932301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.
    Stefani A; Lozano AM; Peppe A; Stanzione P; Galati S; Tropepi D; Pierantozzi M; Brusa L; Scarnati E; Mazzone P
    Brain; 2007 Jun; 130(Pt 6):1596-607. PubMed ID: 17251240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.
    Pienaar IS; Harrison IF; Elson JL; Bury A; Woll P; Simon AK; Dexter DT
    Brain Struct Funct; 2015 Jan; 220(1):479-500. PubMed ID: 24292256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the pedunculopontine nucleus in controlling gait and sleep in normal and parkinsonian monkeys.
    Karachi C; Francois C
    J Neural Transm (Vienna); 2018 Mar; 125(3):471-483. PubMed ID: 28084536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local and Relayed Effects of Deep Brain Stimulation of the Pedunculopontine Nucleus.
    Garcia-Rill E; Tackett AJ; Byrum SD; Lan RS; Mackintosh SG; Hyde JR; Bisagno V; Urbano FJ
    Brain Sci; 2019 Mar; 9(3):. PubMed ID: 30889866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's disease.
    Pienaar IS; Gartside SE; Sharma P; De Paola V; Gretenkord S; Withers D; Elson JL; Dexter DT
    Mol Neurodegener; 2015 Sep; 10():47. PubMed ID: 26394842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson's Disease.
    Elson JL; Kochaj R; Reynolds R; Pienaar IS
    Neurotox Res; 2018 Jul; 34(1):16-31. PubMed ID: 29218504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.